CBLL CIK: 1861107

Ceribell, Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
Change from FY22 to FY25
millions USD
FY22:
21.5
FY23:
38.2
FY24:
56.8
FY25:
78.3
(positive)
Change from FY22 to FY25
millions USD
FY22:
−36.0
FY23:
−30.0
FY24:
−39.7
FY25:
−58.4
(positive)
Change from FY22 to FY25
millions USD
FY22:
−34.9
FY23:
−26.6
FY24:
−35.8
FY25:
−50.2
(positive)
Change from FY22 to FY25
millions USD
FY22:
−37.2
FY23:
−29.5
FY24:
−40.5
FY25:
−53.4
(positive)
Change from FY22 to FY25
millions USD
FY22:
−37.2
FY23:
−29.5
FY24:
−40.5
FY25:
−53.4

All amounts in millions USD FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far. Data sources:SEC EDGARTwelve Data